Home / WINT : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does WINT make money? Does WINT have pricing power? What's the Earnings Whisper? Will WINT profit more as the business scales? What is WINT's management track record? Is WINT's current price justified?

Windtree Therapeutics, Inc.

$0 -$0.03 (-99.33%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

Day Range

$0$0.01

Year Range

$0$0.19

Market Cap

6.74K

AVG Volume

106.86K

Trailing/Forward PE

-0/-

PEG ratio

-0

Dividend Yield

Next Earnings Date

2026-11-26

Primary Exchange

Other OTC

Revenue (USD)

WINT Revenue (USD) by year
Period	Revenue (USD)
2024	90K
2023	0
2022	0
2021	0
2020	23.68M
2019	198K
2018	1.79M
2017	1.49M
2016	2.04M
2015	987K

Net Income (USD)

WINT Net Income (USD) by year
Period	Net Income (USD)
2024	-1.79M
2023	-20.29M
2022	-38.2M
2021	-67.64M
2020	-32.57M
2019	-27.48M
2018	-20.53M
2017	-18.45M
2016	-39.49M
2015	-55.17M

Operating Income (USD)

WINT Operating Income (USD) by year
Period	Operating Income (USD)
2024	-26.14M
2023	-20.6M
2022	-41.33M
2021	-77.28M
2020	-30.32M
2019	-24.89M
2018	-16.2M
2017	-22.55M
2016	-38.04M
2015	-39.83M

EBITDA (USD)

WINT EBITDA (USD) by year
Period	EBITDA (USD)
2024	-1.16M
2023	-20.06M
2022	-39.46M
2021	-76.64M
2020	-32.28M
2019	-25.87M
2018	-18.96M
2017	-16.38M
2016	-36.19M
2015	-48.84M

Cash Flows (USD)

WINT Cash Flows (USD) by year
Period	Cash Flows (USD)
2024	-15.41M
2023	-13.45M
2022	-19.46M
2021	-23.94M
2020	-25.61M
2019	-24.85M
2018	-15.78M
2017	-21.07M
2016	-33.87M
2015	-33.96M

EPS (USD)

WINT EPS (USD) by year
Period	EPS (USD)
2024	-157.85
2023	-7308.57
2022	-56793.15
2021	-121341
2020	-94297
2019	-113116
2018	-876022
2017	-7499516
2016	-167002.84
2015	-477.13

Expenses (USD)

WINT Expenses (USD) by year
Period	Expenses (USD)
2024	25.01M
2023	17.53M
2022	21.9M
2021	32.54M
2020	30.61M
2019	25.28M
2018	17.98M
2017	24.06M
2016	40.36M
2015	40.35M

Cash & Debt (USD)

WINT Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2024	1.78M
2023	4.32M
2022	6.17M
2021	22.35M
2020	16.93M
2019	22.58M
2018	25.15M
2017	1.81M
2016	5.59M
2015	38.72M

Debt ratios

WINT Debt ratios by year
Period	Debt ratios
2024	-0
2023	-0.07
2022	0.02
2021	0.13
2020	0.14
2019	0.17
2018	0.14
2017	-0.09

Margins

WINT Margins by year
Period	Margins
2024	-141.11%
2020	0%
2019	-6307.58%
2018	-490.72%
2017	-1070.1%
2016	-1534.77%
2015	-2102.13%
2014	5.78%

Return on Capital

WINT Return on Capital by year
Period	Return on Capital
2024	-17.88%
2023	-598.38%
2022	-381.57%
2021	-161.5%
2020	-46.82%
2019	-36.67%
2018	-30.15%
2017	77.12%
2016	136.98%
2015	-667.43%

Shares Outstanding

WINT Shares Outstanding by year
Period	Shares Outstanding
2024	256.4K
2023	6.66K
2022	858
2021	626
2020	375
2019	256
2018	53
2017	17
2016	3
2015	2

Book Value Per Share (USD)

WINT Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2024	38.99
2023	509.01
2022	11669
2021	66902.56
2020	185472
2019	292714.84
2018	1285169.81
2017	-1407058.82
2016	-9610000
2015	4133000

Total Assets (USD)

WINT Total Assets (USD) by year
Period	Total Assets (USD)
2024	27.88M
2023	32.41M
2022	37.95M
2021	74.79M
2020	112.89M
2019	118.97M
2018	119.4M
2017	3.35M
2016	9.7M
2015	44.38M

Employee Count

WINT Employee Count by year
Period	Employee Count
2024	14
2023	15
2022	20
2021	33
2020	31
2019	32
2018	33
2017	27
2016	49
2015	58

Free Cash Flow Yield

WINT Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-283430178.07%
Sep 26	-188953452.05%
Aug 26	-566860373.14%
Aug 26	-566860356.14%
Aug 26	-283430178.07%
Aug 26	-283430178.07%
Jul 26	-141715089.03%
Jul 26	-566860356.14%
Jul 26	-4307449.51%
Jul 26	-3531840.23%
Jul 26	-3724443.86%
Jun 26	-4049002.54%
Jun 26	-3336435.29%
Jun 26	-3149224.2%
Jun 26	-3936530.25%
May 26	-3991974.34%
May 26	-4020286.21%
May 26	-3334472.68%
May 26	-2862931.09%
May 26	-2636559.8%
Apr 26	-2267441.42%
Apr 26	-3354203.29%
Apr 26	-3374168.79%
Apr 26	-5503498.6%
Mar 26	-6030429.32%
Mar 26	-4723836.3%
Mar 26	-5612478.77%
Mar 26	-4198965.6%
Feb 26	-5347739.21%
Feb 26	-4723836.3%
Feb 26	-5668603.56%
Feb 26	-5668603.56%
Jan 26	-2834301.78%
Jan 26	-2834301.78%
Jan 26	-2834301.78%
Jan 26	-1889534.52%
Jan 26	-1889534.52%
Dec 25	-1889534.52%
Dec 25	-1417150.89%
Dec 25	-1028784.68%
Dec 25	-944767.26%
Nov 25	-1417150.89%
Nov 25	-944767.26%
Nov 25	-4450335.39%
Nov 25	-4450335.39%
Oct 25	-3115234.78%
Oct 25	-2596028.98%
Oct 25	-2396334.44%
Oct 25	-1730685.99%
Oct 25	-3894043.47%
Sep 25	-3894043.47%
Sep 25	-3894043.47%
Sep 25	-5192057.96%
Sep 25	-4450335.39%
Aug 25	-3115234.78%
Aug 25	-2396334.44%
Aug 25	-266783.99%
Aug 25	-249719.96%
Aug 25	-227706.65%
Jul 25	-139435.47%
Jul 25	-114829.21%
Jul 25	-187187.34%
Jul 25	-147058.5%
Jun 25	-303997.24%
Jun 25	-239731.16%
Jun 25	-230822.23%
Jun 25	-240532.94%
May 25	-179562.1%
May 25	-175413.04%
May 25	-165032.32%
May 25	-7054.41%
May 25	-6038.95%
Apr 25	-4968.41%
Apr 25	-5273.48%
Apr 25	-64829.49%
Apr 25	-66325.56%
Mar 25	-55271.3%
Mar 25	-58258.94%
Mar 25	-42060.11%
Mar 25	-45380.64%
Feb 25	-27114.22%
Feb 25	-19821.43%
Feb 25	-12550.69%
Feb 25	-14688.79%
Jan 25	-13204.17%
Jan 25	-9623.13%
Jan 25	-7867.08%
Jan 25	-6757.31%
Jan 25	-5412.63%
Dec 24	-5562.79%
Dec 24	-5385.59%
Dec 24	-4879.64%
Dec 24	-4660.71%
Nov 24	-3250.03%
Nov 24	-4398.31%
Nov 24	-4655.61%
Nov 24	-3781.79%
Nov 24	-3068.44%
Oct 24	-2561.18%
Oct 24	-2422.1%

Price to Sales

WINT Price to Sales by year
Period	Price to Sales
Sep 26	0
Sep 26	0
Aug 26	0
Aug 26	0
Aug 26	0
Aug 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jun 26	0
Jun 26	0.01
Jun 26	0.01
Jun 26	0
May 26	0
May 26	0
May 26	0.01
May 26	0.01
May 26	0.01
Apr 26	0.01
Apr 26	0.01
Apr 26	0
Apr 26	0
Mar 26	0
Mar 26	0
Mar 26	0
Mar 26	0
Feb 26	0
Feb 26	0
Feb 26	0
Feb 26	0
Jan 26	0.01
Jan 26	0.01
Jan 26	0.01
Jan 26	0.01
Jan 26	0.01
Dec 25	0.01
Dec 25	0.01
Dec 25	0.02
Dec 25	0.02
Nov 25	0.01
Nov 25	0.02
Nov 25	0
Nov 25	0
Oct 25	0.01
Oct 25	0.01
Oct 25	0.01
Oct 25	0.01
Oct 25	0
Sep 25	0
Sep 25	0
Sep 25	0
Sep 25	0
Aug 25	0.01
Aug 25	0.01
Aug 25	0.06
Aug 25	0.07
Aug 25	0.07
Jul 25	0.12
Jul 25	0.14
Jul 25	0.09
Jul 25	0.11
Jun 25	0.05
Jun 25	0.07
Jun 25	0.07
Jun 25	0.07
May 25	0.09
May 25	0.09
May 25	0.1
May 25	2.43
May 25	2.84
Apr 25	3.45
Apr 25	3.25
Mar 22	1.17
Mar 22	1.19
Mar 22	1.12
Mar 22	1.15
Feb 22	1.19
Feb 22	1.19
Feb 22	1.23
Feb 22	1.43
Jan 22	1.19
Jan 22	1.48
Jan 22	1.68
Jan 22	1.56
Dec 21	1.81
Dec 21	1.78
Dec 21	1.84
Dec 21	1.84
Dec 21	1.68
Nov 21	1.98
Nov 21	1.76
Nov 21	2.01
Nov 21	2.02
Oct 21	1.98
Oct 21	2.09
Oct 21	2.54
Oct 21	2.54
Oct 21	2.31

Price to Book

WINT Price to Book by year
Period	Price to Book
Nov 25	0
Nov 25	0
Oct 25	0
Oct 25	0
Oct 25	0
Oct 25	0
Oct 25	0
Sep 25	0
Sep 25	0
Sep 25	0
Sep 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Jul 25	0
Jul 25	0
Jul 25	0
Jul 25	0
Jun 25	0
Jun 25	0
Jun 25	0
Jun 25	0
May 25	0
May 25	0
May 25	0
May 25	0.02
May 25	0.03
Apr 25	0.03
Apr 25	0.03
Apr 25	0.01
Apr 25	0.01
Mar 25	0.01
Mar 25	0.01
Mar 25	0.01
Mar 25	0.01
Feb 25	0.01
Feb 25	0.02
Feb 25	0.03
Feb 25	0.02
Jan 25	0.03
Jan 25	0.04
Jan 25	0.04
Jan 25	0.05
Jan 25	0.06
Dec 24	0.06
Dec 24	0.06
Dec 24	0.07
Dec 24	0.07
Nov 24	0.11
Nov 24	0.08
Nov 24	0.08
Nov 24	0.1
Nov 24	0.12
Oct 24	0.14
Oct 24	0.15
Oct 24	0.12
Oct 24	0.18
Sep 24	0.42
Sep 24	0.52
Sep 24	0.52
Sep 24	0.46
Aug 24	1.33
Aug 24	1.75
Aug 24	0.36
Aug 24	0.37
Aug 24	0.25
Jul 24	0.25
Jul 24	0.11
Jul 24	0.12
Jul 24	0.1
Jun 24	0.1
Jun 24	0.09
Jun 24	0.09
Jun 24	0.1
May 24	0.11
May 24	0.12
May 24	0.14
May 24	0.4
May 24	0.49
Apr 24	0.51
Apr 24	0.6
Apr 24	0.3
Apr 24	0.29
Mar 24	0.24
Mar 24	0.25
Mar 24	0.23
Mar 24	0.27
Mar 24	0.27
Feb 24	0.22
Feb 24	0.24
Feb 24	0.25
Feb 24	0.28
Jan 24	0.3
Jan 24	0.35
Jan 24	0.39
Jan 24	0.43
Dec 23	0.49
Dec 23	0.5

No video analysis for this stock yet. Request one from our team.

News: WINT

prnewswire.com · 10 Sep 2026

TransCode Therapeutics Announces Leadership Transition

Tom Fitzgerald, Chief Financial Officer, Announces his Retirement John Tattory, to become Interim Chief Financial Officer BOSTON, Sept. 10, 2026 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA for the treatment of high risk and advanced cancer, today announced the retirement of its Chief Financial Officer, Tom Fitzgerald.

AI Analysis

Windtree Therapeutics, Inc.

Video analysis: WINT

News: WINT

TransCode Therapeutics Announces Leadership Transition

Similar companies